Golden Ally Lifetech Group, Inc.
AQPW
$0.2694
$0.049322.40%
| 03/31/2023 | 12/31/2022 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 141.03% | -29.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 123.43% | -23.41% | |||
| Operating Income | -123.43% | 23.41% | |||
| Income Before Tax | -123.43% | 23.41% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -123.43% | 23.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -123.43% | 23.41% | |||
| EBIT | -123.43% | 23.41% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -200.00% | 50.00% | |||
| Normalized Basic EPS | -- | 100.00% | |||
| EPS Diluted | -200.00% | 50.00% | |||
| Normalized Diluted EPS | -- | 100.00% | |||
| Average Basic Shares Outstanding | -57.39% | 105.11% | |||
| Average Diluted Shares Outstanding | -57.39% | 105.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
